SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $316,000 | +1.9% | 11,890 | -4.3% | 0.14% | -7.5% |
| Q4 2020 | $310,000 | +11.5% | 12,420 | -7.0% | 0.15% | -9.9% |
| Q3 2020 | $278,000 | -12.3% | 13,353 | 0.0% | 0.16% | -16.5% |
| Q2 2020 | $317,000 | +32.1% | 13,353 | -3.1% | 0.19% | -1.5% |
| Q1 2020 | $240,000 | -29.6% | 13,776 | -4.2% | 0.20% | -6.6% |
| Q4 2019 | $341,000 | -14.8% | 14,374 | -1.3% | 0.21% | -22.1% |
| Q3 2019 | $400,000 | +18.7% | 14,564 | +43.1% | 0.27% | +24.9% |
| Q2 2019 | $337,000 | -8.4% | 10,180 | -3.1% | 0.22% | -3.6% |
| Q1 2019 | $368,000 | +7.3% | 10,504 | 0.0% | 0.22% | -5.1% |
| Q4 2018 | $343,000 | -37.5% | 10,504 | -4.4% | 0.24% | -20.7% |
| Q3 2018 | $549,000 | – | 10,984 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |